Search
Now showing items 1-5 of 5
Article
VIP plasma levels associate with survival in severe COVID-19 patients, correlatingwith protective effects in SARS-CoV-2-infected cells
| Date Issued:
2022 | Copyright:
open access
Article
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
| Date Issued:
2021 | Copyright:
open access
Article
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
| Date Issued:
2020 | Copyright:
open access
Article
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
| Date Issued:
2022 | Copyright:
open access
Article
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
| Date Issued:
2021 | Copyright:
open access